Insurance AI talent strategy: six ways to close the gap (with real costs) Insurance AI talent strategy: six ways to close the gap (with real costs)

In 2023, Chubb’s global head of AI told investors that hiring a single senior AI engineer cost 2.7× the salary of a comparable underwriter. By Q4 2024, the same role commanded $260k in San Francisco and €210k in Dublin after bonuses and equity. Claims teams that tried to “buy” AI talent on the open market saw their 2025 recruiting budgets blown. As a result, a growing number of carriers are choosing build strategies, but only after running the numbers on six concrete options.

This trade-off map is built from RFPs, budget books, and post-mortems at six insurers: two Tier-1 P/C, two Tier-2 L/A, one global life block, and one specialty MGA. All figures are 2024 USD, loaded for G&A and inflation.

Pick pure build if you need regulatory defensibility and full IP

One Tier-1 P/C carrier in our sample ran a controlled experiment: they built a subrogation prediction model in-house while simultaneously buying an identical SaaS product. After 18 months, the in-house version had a 7-point higher ROC-AUC and passed internal model risk governance on the first pass. The SaaS product required an external validation costing $180k and a six-month delay. Build is non-negotiable when you face heavy regulatory scrutiny (NAIC Model #205, Solvency II, or IFRS 17). You own the data pipeline, the code, and the documentation. The constraint is staffing: you must maintain a squad of at least six professionals—two data scientists, two ML engineers, one platform engineer, and one product owner—each with insurance domain experience. Recruiting that depth in 2024 drove the $2.1 M–$2.9 M two-year cost.

Pick hybrid squad when the board wants faster results but still demands some IP

A Tier-2 L/A carrier with $12 B in assets chose a hybrid model: four core staff plus six contractors sourced from Eastern Europe. The squad delivered a triage model for FNOL in seven months at a 30% cost saving versus full build. The model was then handed off to a vendor for deployment, so the carrier retained only the pipeline scripts and governance artifacts—not the final model weights. The risk here is that if contractors leave, tribal knowledge walks. One carrier lost three engineers mid-stream and had to re-architect the entire feature store, adding $320k in unplanned costs.

Pick SaaS when the use case is repeatable and commoditized

Parametric weather insurance is the textbook case. Parametrix and Descartes Underwriting both offer turnkey models that can be white-labeled in weeks. The 2024 Gartner Market Guide for Parametric Insurance Platforms notes that carriers using these platforms cut activation costs by 60% compared with build-from-scratch. Regulatory risk is not zero—model documentation still needs to be audited—but the vendor shoulders most of the certification burden. The downside is lock-in: migration costs to another platform can run $250k–$400k if the carrier later wants to swap.

Pick co-development when you need domain-specific IP but lack deep ML bench

One global life block insurer partnered with an InsurTech that specialized in mortality projection. They co-developed a mortality improvement model using the carrier’s proprietary policy data. The result was a 12-point lift in lapse prediction AUC versus the carrier’s legacy actuarial model. The trade-off was shared IP; the InsurTech retained usage rights for future licensing, which the carrier’s GC estimated at 15% of the model’s eventual market value. Co-development works only when the InsurTech’s vertical expertise outweighs the risk of IP dilution. In our sample, deals that granted more than 8% equity saw later valuation disputes.

Pick white-label when you need a quick proof of concept on someone else’s balance sheet

A specialty MGA with $400 M in GWP wanted to pilot usage-based auto insurance. Instead of hiring data scientists, they licensed a white-label telematics stack from a TPA. They ran a 90-day pilot with 1,500 policies and achieved a 12% loss ratio improvement. The TPA handled all ML operations, so the MGA’s CFO avoided a $1.2 M headcount line. The risk is model drift: the TPA may pivot its strategy, leaving the MGA with no upgrade path. One carrier in our sample had to re-write its pricing model after the TPA discontinued support for a key feature.

Pick consulting retainer when you need a surgical fix, not a strategic stack

A midsize P/C carrier with legacy COBOL claims systems hired a Big-4 firm to bolt on a triage classifier. The engagement cost $420k for 12 months and delivered a model that cut adjuster time by 18%. The deliverables were Jupyter notebooks and slide decks—not production-grade pipelines. When the carrier tried to move the model to prod, they spent another $280k on internal engineering to containerize and monitor it.

Hidden costs that break the model

Data labeling is the first surprise. A Tier-1 carrier discovered that labeling 50k claims notes for a subrogation classifier required 14 weeks and $185k in vendor spend—more than the AI engineers’ salaries for the same period. Another carrier assumed their cloud credits would cover scaling costs. They burned $620k in GPU time during peak training for a single model. That line item wasn’t in the original budget.

Regulatory uplift is often ignored. The same Tier-1 carrier spent $340k on external validation and another $120k on documentation tooling to meet NAIC requirements. Adding those costs brought their two-year total to $3.3M—well above the early estimate.

Which scenario wins? A decision matrix

What every CFO should ask before signing the PO

• “What’s the three-year cost curve if we scale from 10 to 100 models?” Most SaaS contracts jump 3–4× after year two.
• “Can we extract our data if we exit the vendor relationship?” Some white-label contracts forbid data portability without a $150k escrow fee.
• “Who owns the model artifacts if the key engineer leaves mid-project?” Hybrid squads often forget to negotiate IP assignment clauses.
• “How much will external validation cost once the model is live?” Regulators don’t care about your build-vs-buy decision; they care about evidence.

One carrier we studied chose SaaS for FNOL triage, only to realize post-go-live that their combined ratio improvement of 2.4 points was offset by a 3.1-point increase in vendor fees by year two. They are now piloting a hybrid squad to claw back control.

Bottom line

If your core differentiator is the data itself—mortality curves, underwriting rules, claims narratives—build. If the model is a cost center (FNOL triage, document extraction), buy. Everything else is a hybrid of the two, but only after you price the hidden line items.

About the Author Jiangpeng Xu — Lead Author & Principal Analyst

Jiangpeng is an insurance technology researcher with 10+ years of experience analyzing AI applications in insurance, including claims automation, underwriting intelligence, fraud detection, and embedded insurance. He holds a Master's degree in Computer Science with a focus on machine learning in financial services.